Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Barr re-introduces generic drug for pain

Oct. 18, 1996

Tentative FDA approval for generic analgesic

Oct. 18, 1996

Merck & Co. reveals new series of tachykinin antagonists

Oct. 18, 1996

Yamanouchi's CNS products in the pipeline

Oct. 11, 1996

Novel treatment for chronic fatigue syndrome available in Canada

Oct. 11, 1996

Novel free radical-scavenging and neuroprotective substance isolated by Japanese researchers

Oct. 11, 1996

Calpain inhibitors reported by Warner-Lambert

Oct. 11, 1996

New muscarinic antagonists from Schering-Plough

Oct. 11, 1996

Copaxone approvable for MS

Oct. 11, 1996

FDA approval for Taro generic drug

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...